Jewell Christopher M
Insider CIK 2000226 · RNAC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2025-01-10 | 2025-01-13 | 9,000 | — | $0 | 67,432 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2025-01-10 | 2025-01-13 | 9,000 | $3.23 | $29.1K | 62,490 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-06 | 2025-01-07 | 1,286 | $16.83 | $21.6K | 53,490 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-03 | 2025-01-07 | 1,264 | $16.72 | $21.1K | 54,776 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 47,400 | — | $0 | 47,400 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 16,100 | — | $0 | 56,040 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-20 | 2024-11-21 | 14,000 | — | $0 | 76,432 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-20 | 2024-11-21 | 14,000 | $3.23 | $45.2K | 39,940 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-15 | 2024-11-18 | 16,065 | — | $0 | 90,432 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-15 | 2024-11-18 | 16,065 | $3.23 | $51.9K | 42,005 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-15 | 2024-11-18 | 16,065 | $17.06 | $274.1K | 25,940 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-14 | 2024-11-18 | 36,050 | — | $0 | 106,497 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-14 | 2024-11-18 | 17,500 | $17.02 | $297.9K | 25,940 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-14 | 2024-11-18 | 18,550 | $16.34 | $303.1K | 43,440 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-14 | 2024-11-18 | 36,050 | $3.23 | $116.4K | 61,990 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 4,276 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 142,547 | — | $0 | 142,547 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-01-02 | 2024-01-04 | 998,000 | — | $0 | 998,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-01-02 | 2024-01-04 | 778,200 | — | $0 | 778,200 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2023-11-13 | 2023-11-15 | 4,276 | — | $0 | 4,276 | SEC↗ |